NYSE:IVC

Invacare (IVC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.35
$0.74
52-Week Range
N/A
Volume
33,301 shs
Average Volume
240,305 shs
Market Capitalization
$20.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IVC stock logo

About Invacare Stock (NYSE:IVC)

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

IVC Stock News Headlines

Buckeye Trail coasts past Newcomerstown for key IVC win
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
IL&FS Investment Managers Limited (IVC.NS)
Invacare Reports Results for First Quarter 2023
The Hard Truth About Investing For Retirement
Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.
Invacare files for bankruptcy
Why Is Invacare (IVC) Stock Down 20% Today?
Invacare draws more on term loan from hedge fund manager
Invacare picks Geoff Purtill as permanent president, CEO
Invacare Third Quarter 2022 Earnings: Misses Expectations
Invacare Reports Results for Third Quarter 2022
See More Headlines
Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/27/2021
Today
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
CUSIP
46120310
Employees
3,000
Year Founded
1885

Profitability

Net Income
$-45,560,000.00
Pretax Margin
-9.38%

Debt

Sales & Book Value

Annual Sales
$872.46 million
Book Value
$5.54 per share

Miscellaneous

Free Float
35,153,000
Market Cap
$20.01 million
Optionable
Optionable
Beta
0.38

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives


IVC Stock Analysis - Frequently Asked Questions

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) issued its quarterly earnings data on Wednesday, October, 27th. The health services provider reported ($0.12) EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.08. The health services provider had revenue of $224.20 million for the quarter, compared to analyst estimates of $222.27 million. Invacare had a negative trailing twelve-month return on equity of 37.76% and a negative net margin of 9.99%. During the same quarter in the prior year, the firm posted ($0.10) EPS.

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare Chief Executive Officer Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among the company's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

This page (NYSE:IVC) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners